Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference

    NEXT STORY
    AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference
    PREV STORY
    OSE Immunotherapeutics Receives Notice of Allowance for New U.S. Patent Protecting Anti-IL-7 Receptor Antagonist OSE-127
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Athenex, Inc. Announces Grant Disbursement Agreement with New York State for Dunkirk Facility

    In a release issued earlier today by Athenex, Inc. (Nasdaq:ATNX), please note that the ...

    author_avatar
    NASDAQ Market News

    Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Gene Therapy for Wet AMD

    author_avatar
    NASDAQ Market News

    Genocea to Present at 29th Annual Piper Jaffray Healthcare Conference

    CAMBRIDGE, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company ...

    author_avatar
    NASDAQ Market News